Drägerwerk AG & Co. KGaA, an international operator in the fields of medical and safety technology, has acquired a majority stake in the Swiss-based start-up medical technology company STIMIT. VISCHER advised Stimit and the sellers with a team led by Matthias Staehelin with Pauline Pfirtner (both Corporate) and Nadia Tarolli (Tax). STIMIT works on solutions to […]
Bär & Karrer advised Leoni AG – a leading German wire, cable and harnessing manufacturing group – on the sale of its subsidiary Leoni Schweiz AG to a consortium of buyers led by former board member
Lightrock, a leading global impact investor backed by LGT and the Princely House of Liechtenstein, announced its minority investment of 10% in South Pole Holding, one of the world’s largest companies fully focused on fighting
Vischer advised the sellers of Mestex AG on all legal issues related to the sale of their shares and stock options to the pharmaceutical company Grünenthal, a global operator in pain management and related
Bamcam Holding AG sold all shares in Radio-Onkologie Amsler AG to stock exchange listed Atrys Health Group. The acquisition is part of Atrys Health’s long-term strategy to create a pan-European network of oncology
Baker McKenzie has advised Schaffner, a global operator in solutions that ensure the efficient and reliable operation of power electronic systems by shaping electrical power, on the sale of its Power Magnetics Division to Swedish
MLL assisted the Dutch private equity firm Nimbus and its portfolio company Bontexgeo in the acquisition of the Swiss company Stratex. The team was led by Mona Stephenson (Partner, M&A – pictured) and included
ISS, a global leading facility services provider, has agreed to sell its Swiss subsidiary ISS Kanal Services to KLAR Partners, a pan-European investment firm with a focus on investments in business services and industrial sectors,
Unsere Champions, a successful operator of day nurseries and kindergartens in southern Germany, acquired, for the first time, various childcare facilities in the German-speaking part of Switzerland from private sellers. Vischer advised Unsere Champions on
Grünenthal announced the acquisition of Mestex through the purchase of all of its shares and outstanding options. Mestex is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the
